Pharmaceutical big Pfizer Inc and German biotech agency BioNTech SE on Wednesday mentioned that they had signed a deal to produce Canada with an experimental coronavirus vaccine.
Deliveries of the BNT162 mRNA-based vaccine candidate are deliberate over the course of 2021, topic to scientific success and Health Canada approval, the 2 firms mentioned in a press release. They didn’t reveal monetary particulars.
Separately, the Canadian authorities mentioned it might make an announcement on the subsequent steps in procuring vaccines at 10 a.m. ET (1400 GMT) on Wednesday.
There aren’t any accepted vaccines for the sickness brought on by the brand new coronavirus, however 19 vaccines are being examined in people around the globe.